Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017149179) ANAESTHETIC SOLUTION AND METHOD OF USE THEREOF FOR ANAESTHETISING, STUNNING AND SLAUGHTERING FISH
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/149179 International Application No.: PCT/ES2017/070108
Publication Date: 08.09.2017 International Filing Date: 27.02.2017
IPC:
A61K 47/40 (2006.01) ,A61K 31/085 (2006.01) ,A61P 23/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
30
Macromolecular compounds
36
Polysaccharides; Derivatives thereof
40
Cyclodextrins; Derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
075
Ethers or acetals
085
having an ether linkage to aromatic ring nuclear carbon
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
23
Anaesthetics
Applicants:
UNIVERSIDAD POLITECNICA DE CARTAGENA [ES/ES]; Plaza Cronista Isidoro Valverde, s/n Ed. La Milagrosa 30202 Cartagena (Murcia), ES
Inventors:
GARCIA AYALA, Alfonsa; ES
LOPEZ CÁNOVAS, Amanda Esperanza; ES
LOPEZ GOMEZ, Antonio; ES
MULERO MENDEZ, Victoriano, Francisco; ES
ROS CHUMILLAS, Maria; ES
Agent:
CARPINTERO LOPEZ, Mario; ES
Priority Data:
P20163025804.03.2016ES
Title (EN) ANAESTHETIC SOLUTION AND METHOD OF USE THEREOF FOR ANAESTHETISING, STUNNING AND SLAUGHTERING FISH
(FR) SOLUTION ANESTHÉSIANTE ET SON PROCÉDÉ D'APPLICATION POUR L’ANESTHÉSIE, L’ÉTOURDISSEMENT ET L’ABATTAGE DES POISSONS
(ES) SOLUCIÓN ANESTESIANTE Y SU MÉTODO DE APLICACIÓN PARA EL ANESTESIADO, ATURDIDO Y SACRIFICIO DE PECES
Abstract:
(EN) The invention relates to an anaesthetic solution comprising a natural anaesthetising agent (clove essential oil, isoeugenol and/or eugenol) nanoencapsulated in food-grade β-cyclodextrines, with a moisture content no greater than 14%, forming a water-soluble inclusion complex, wherein the proportion of natural anaesthetic in the inclusion complex is between 5 and 30%, the proportion of β-cyclodextrines being between 70 and 95% of the total mass of the complex. According to the invention the anaesthetising agent is formulated in freshwater, seawater, liquid ice or water with crushed ice, in a concentration between 5 and 60 mg/kg of water. The invention also relates to methods developed for anaesthetising, stunning and/or slaughtering fish, based on the use of the solution of invention.
(FR) L’invention concerne une solution anesthésiante qui comprend un agent anesthésiant naturel (huile essentielle de clou de girofle, d’isoeugénol et/ou d’eugénol), nanoencapsulé dans des β-cyclodextrines à usage alimentaire, avec une teneur en eau ne dépassant pas les 14%, formant un complexe d'inclusion soluble dans l'eau, la proportion de l’anesthésiant naturel dans le complexe d'inclusion étant compris entre 5 et 30%, la proportion des β-cyclodextrines entre 70 et 95%, de la masse totale du complexe, dans laquelle l’agent anesthésiant est composé d’eau douce, d’eau de mer, de glace liquide ou d’eau avec de la glace pilée, dans une concentration comprise entre 5 et 60 mg/kg d’eau. L’invention porte également sur des procédés développés pour l’anesthésie, l’étourdissement et/ou l’abattage des poissons basés sur l’utilisation de la solution de l’invention.
(ES) Esta invención se refiere a una solución anestesiante que comprende un agente anestesiante natural (aceite esencial de clavo, isoeugenol y/o eugenol), nanoencapsulado en β-ciclodextrinas de uso alimentario,con un contenido de humedad no superior al 14%, formando un complejo de inclusión soluble en agua, donde la proporción del anestesiante natural en el complejo de inclusión está comprendida entre el 5 y el 30%, la proporción de las β-ciclodextrinas entre el 70 y el 95%, de la masa total del complejo, en la que el agente anestesiante se formula en agua dulce, agua de mar, hielo líquido o agua con hielo picado, en una concentración comprendida entre 5 y 60 mg/kg de agua. Asimismo se contemplan los métodos desarrollados para el anestesiado, aturdido y/o sacrificio de los peces basados en el empleo de la solución de la invención.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Spanish (ES)
Filing Language: Spanish (ES)